MIAT and non-small cell lung carcinoma: MIAT (located at 22q12.1) was originally identified as a myocardial infarction susceptibility locus14, and its expression was reportedly upregulated in association with ischemic stroke, myocardial infarction, non-small-cell lung cancer, and chronic lymphocytic leukemia15,16.